Ju Jiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ju Jiao has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Yujie Xie
Department of Nuclear Medicine The Third Affiliated Hospital of Sun Yat‐Sen University Guangzhou China
4 shared publications - Ka-Leung Wong
Department of Chemistry City University of Hong Kong Kowloon Hong Kong SAR China
3 shared publications - Qiong Zou
Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
3 shared publications - Yong Zhang
Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
3 shared publications - Edward R. H. Walter
Department of Chemistry Imperial College London Molecular Sciences Research Hub London UK
2 shared publications Feilong Liu
Department of Applied Biology and Chemical Technology The Hong Kong Polytechnic University Hung Hom Hong Kong SAR China
2 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Wiley in Angewandte Chemie International Edition
- p. e6507556
Facile Synthesis of a Bis‐ α ‐aryl‐Substituted Pyclen‐Based Heptadentate Lanthanide Chelator for Ultra‐Robust and High‐Contrast MRI Agents and for Radiopharmaceuticals
Owing to safety concerns associated with previous gadolinium‐based magnetic resonance imaging (MRI) agents, pyclen‐based Gd chelates are emerging as promising alternatives. However, the development of pyclen‐based chelators has been hindered by synthetic challenges. In this work, we report two new pyclen‐based chelators featuring α ‐aryl‐substituents on two of the acetate arms. Using the Petasis reaction, two lanthanide chelators 3a and 3b were synthesized in just two steps from pyclen. 3a‐Gd exhibits superior coordination stability and relaxivity compared to previously reported Gd 3+ chelates of comparable molecular weight. It also has low cytotoxicity and produces a strong, long‐lasting in vivo MRI signal, enabling real‐time monitoring of tissues/organs, as demonstrated in heart, liver, and kidney imaging of mice. Additionally, the chelator also shows improved coordination kinetics for In 3+ , Tb 3+ , Lu 3+ , and Y 3+ , highlighting its potential for the development of a new class of next‐generation radiopharmaceuticals.
- 29 October 2026
- Published by Wiley in Angewandte Chemie International Edition
- p. e6507556
Open AccessFacile Synthesis of a Bis‐ α ‐aryl‐Substituted Pyclen‐Based Heptadentate Lanthanide Chelator for Ultra‐Robust and High‐Contrast MRI Agents and for Radiopharmaceuticals
Owing to safety concerns associated with previous gadolinium‐based magnetic resonance imaging (MRI) agents, pyclen‐based Gd chelates are emerging as promising alternatives. However, the development of pyclen‐based chelators has been hindered by synthetic challenges. In this work, we report two new pyclen‐based chelators featuring α ‐aryl‐substituents on two of the acetate arms. Using the Petasis reaction, two lanthanide chelators 3a and 3b were synthesized in just two steps from pyclen. 3a‐Gd exhibits superior coordination stability and relaxivity compared to previously reported Gd 3+ chelates of comparable molecular weight. It also has low cytotoxicity and produces a strong, long‐lasting in vivo MRI signal, enabling real‐time monitoring of tissues/organs, as demonstrated in heart, liver, and kidney imaging of mice. Additionally, the chelator also shows improved coordination kinetics for In 3+ , Tb 3+ , Lu 3+ , and Y 3+ , highlighting its potential for the development of a new class of next‐generation radiopharmaceuticals.
- Open Access
- 29 October 2026
- Published by Wiley in Angewandte Chemie
Facile Synthesis of a Bis‐ α ‐aryl‐Substituted Pyclen‐Based Heptadentate Lanthanide Chelator for Ultra‐Robust and High‐Contrast MRI Agents and for Radiopharmaceuticals
Owing to safety concerns associated with previous gadolinium‐based magnetic resonance imaging (MRI) agents, pyclen‐based Gd chelates are emerging as promising alternatives. However, the development of pyclen‐based chelators has been hindered by synthetic challenges. In this work, we report two new pyclen‐based chelators featuring α ‐aryl‐substituents on two of the acetate arms. Using the Petasis reaction, two lanthanide chelators 3a and 3b were synthesized in just two steps from pyclen. 3a‐Gd exhibits superior coordination stability and relaxivity compared to previously reported Gd 3+ chelates of comparable molecular weight. It also has low cytotoxicity and produces a strong, long‐lasting in vivo MRI signal, enabling real‐time monitoring of tissues/organs, as demonstrated in heart, liver, and kidney imaging of mice. Additionally, the chelator also shows improved coordination kinetics for In 3+ , Tb 3+ , Lu 3+ , and Y 3+ , highlighting its potential for the development of a new class of next‐generation radiopharmaceuticals.
- 29 October 2026
- Published by Wiley in Angewandte Chemie
Open AccessFacile Synthesis of a Bis‐ α ‐aryl‐Substituted Pyclen‐Based Heptadentate Lanthanide Chelator for Ultra‐Robust and High‐Contrast MRI Agents and for Radiopharmaceuticals
Owing to safety concerns associated with previous gadolinium‐based magnetic resonance imaging (MRI) agents, pyclen‐based Gd chelates are emerging as promising alternatives. However, the development of pyclen‐based chelators has been hindered by synthetic challenges. In this work, we report two new pyclen‐based chelators featuring α ‐aryl‐substituents on two of the acetate arms. Using the Petasis reaction, two lanthanide chelators 3a and 3b were synthesized in just two steps from pyclen. 3a‐Gd exhibits superior coordination stability and relaxivity compared to previously reported Gd 3+ chelates of comparable molecular weight. It also has low cytotoxicity and produces a strong, long‐lasting in vivo MRI signal, enabling real‐time monitoring of tissues/organs, as demonstrated in heart, liver, and kidney imaging of mice. Additionally, the chelator also shows improved coordination kinetics for In 3+ , Tb 3+ , Lu 3+ , and Y 3+ , highlighting its potential for the development of a new class of next‐generation radiopharmaceuticals.
- Open Access
- 24 August 2026
- Published by Springer Nature in BMC Medical Imaging
- Vol. 26 (1) , 444
Prognostic significance of baseline 18F-FDG PET/CT metabolic quantitative parameters for ampullary adenocarcinoma patients
- 24 August 2026
- Published by Springer Nature in BMC Medical Imaging
- Vol. 26 (1) , 444
Open AccessPrognostic significance of baseline 18F-FDG PET/CT metabolic quantitative parameters for ampullary adenocarcinoma patients
- Open Access
- 1 July 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (7) , 6217-6233
Preliminary study on the ability of 18F-fluorodeoxyglucose positron emission tomography/computed tomography radiomics to predict vessels that encapsulate tumor clusters and prognosis in hepatocellular carcinoma
Background: Recently, a novel vascular pattern characterized by vessels encapsulating tumor clusters (VETC) was reported to be related to poor clinical outcomes in patients with hepatocellular carcinoma (HCC). The objective of this study was to preliminarily assess the ability of metabolic parameters and radiomics features derived from 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) to preoperatively predict VETC and prognosis in HCC patients. Methods: A total of 149 patients diagnosed with HCC from two institutions (The Third Affiliated Hospital of Sun Yat-sen University and Sun Yat-sen Memorial Hospital) were retrospectively enrolled and subsequently divided into a training cohort (n=103) and a test cohort (n=46) as external validation. The correlation between traditional image features on computed tomography (CT)/magnetic resonance imaging (MRI) and 18F-FDG PET/CT and VETC status were evaluated and compared. Radiomics features were extracted from 18F-FDG PET/CT images, followed by calculation of a radiomics score (Radscore). Univariate and multivariate logistic regression analyses were used to screen out the independent indicators. A nomogram model was developed based on Radscore and clinical indicators, and a clinical model was developed based on clinical indicators. The performance of the nomogram, clinical model, Radscore, as well as traditional PET parameter tumor-to-liver ratio (TLR) were evaluated using receiver operating characteristic (ROC) curves and decision curve analysis (DCA). Disease-free survival (DFS) and overall survival (OS) rates were assessed using Kaplan-Meier survival analysis. Results: The difference in FDG parameter TLR between VETC-positive and VETC-negative HCC was found to be statistically significant (PConclusions: FDG metabolism is significantly associated with VETC status in HCC patients. A comprehensive nomogram model based on PET/CT radiomics and clinical indicators has potential for preoperative prediction of VETC as well as patient prognosis.
- 1 July 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (7) , 6217-6233
Open AccessPreliminary study on the ability of 18F-fluorodeoxyglucose positron emission tomography/computed tomography radiomics to predict vessels that encapsulate tumor clusters and prognosis in hepatocellular carcinoma
Background: Recently, a novel vascular pattern characterized by vessels encapsulating tumor clusters (VETC) was reported to be related to poor clinical outcomes in patients with hepatocellular carcinoma (HCC). The objective of this study was to preliminarily assess the ability of metabolic parameters and radiomics features derived from 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) to preoperatively predict VETC and prognosis in HCC patients. Methods: A total of 149 patients diagnosed with HCC from two institutions (The Third Affiliated Hospital of Sun Yat-sen University and Sun Yat-sen Memorial Hospital) were retrospectively enrolled and subsequently divided into a training cohort (n=103) and a test cohort (n=46) as external validation. The correlation between traditional image features on computed tomography (CT)/magnetic resonance imaging (MRI) and 18F-FDG PET/CT and VETC status were evaluated and compared. Radiomics features were extracted from 18F-FDG PET/CT images, followed by calculation of a radiomics score (Radscore). Univariate and multivariate logistic regression analyses were used to screen out the independent indicators. A nomogram model was developed based on Radscore and clinical indicators, and a clinical model was developed based on clinical indicators. The performance of the nomogram, clinical model, Radscore, as well as traditional PET parameter tumor-to-liver ratio (TLR) were evaluated using receiver operating characteristic (ROC) curves and decision curve analysis (DCA). Disease-free survival (DFS) and overall survival (OS) rates were assessed using Kaplan-Meier survival analysis. Results: The difference in FDG parameter TLR between VETC-positive and VETC-negative HCC was found to be statistically significant (PConclusions: FDG metabolism is significantly associated with VETC status in HCC patients. A comprehensive nomogram model based on PET/CT radiomics and clinical indicators has potential for preoperative prediction of VETC as well as patient prognosis.
- 27 June 2025
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 255, 114915
A smart ultra-small near infrared persistent luminescence nanoprobe for non-invasive detection of early rheumatoid arthritis
- 27 June 2025
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 255, 114915
A smart ultra-small near infrared persistent luminescence nanoprobe for non-invasive detection of early rheumatoid arthritis
- 12 November 2022
- Published by Springer Nature in Abdominal Radiology
- Vol. 48 (2) , 532-542
18F-FDG PET/CT-based radiomics nomogram for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma: a two-center study
Purpose To explore the potential of β-2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the evaluation of macrotrabecular-massive (MTM) hepatocellular carcinoma (HCC) and to apply radiomics approach to build a radiomics nomogram for predicting MTM-HCC. Methods This study included 140 (training cohort:101; validation cohort:39) HCC patients who underwent preoperative 18F-FDG PET/CT at two institutions. The clinical features and tumor FDG metabolism measured by the tumor-to-liver ratio (TLR) via 18F-FDG PET/CT were retrospectively collected. Radiomics features were extracted from 18F-FDG PET/CT images and a radiomics score (Rad-score) was calculated. A radiomics nomogram was then constructed by combining Rad-score and independent clinical features and was assessed with a calibration curve. The performance of the radiomics nomogram, Rad-score and TLR was evaluated by receiver operating characteristic (ROC) curves and decision curve analysis (DCA). Results A total of six top weighted radiomics features were selected from PET/CT images by the least absolute shrinkage and selection operator (LASSO) regression algorithm and were used to construct a Rad-score. Multivariate analysis identified Rad-score (OR = 2.183, P = 0.004), age ≤ 50 years (OR = 3.136, P = 0.036), AST > 40U/L (OR = 0.270, P = 0.017) and TLR (OR = 1.641, P = 0.049) as independent predictors of MTM-HCC. The radiomics nomogram had a higher area under the curves (AUCs) than the Rad-score and TLR for predicting MTM-HCC in both training (0.849 [95% CI 0.774–0.924] vs. 0.764 [95% CI 0.669–0.843], 0.763 [95% CI 0.668–0.842]) and validation (0.749 [95% CI 0.584–0.873] vs. 0.690 [95% CI 0.522–0.828], 0.541 [95% CI 0.374–0.701]) cohorts. DCA showed the radiomics nomogram to be more clinically useful than Rad-score and TLR. Conclusions Tumor FDG metabolism is significantly associated with MTM-HCC. A 18F-FDG PET/CT-based radiomics nomogram may be useful for preoperatively predicting the MTM subtype in primary HCC patients, contributing to pretreatment decision-making.
- 12 November 2022
- Published by Springer Nature in Abdominal Radiology
- Vol. 48 (2) , 532-542
18F-FDG PET/CT-based radiomics nomogram for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma: a two-center study
Purpose To explore the potential of β-2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the evaluation of macrotrabecular-massive (MTM) hepatocellular carcinoma (HCC) and to apply radiomics approach to build a radiomics nomogram for predicting MTM-HCC. Methods This study included 140 (training cohort:101; validation cohort:39) HCC patients who underwent preoperative 18F-FDG PET/CT at two institutions. The clinical features and tumor FDG metabolism measured by the tumor-to-liver ratio (TLR) via 18F-FDG PET/CT were retrospectively collected. Radiomics features were extracted from 18F-FDG PET/CT images and a radiomics score (Rad-score) was calculated. A radiomics nomogram was then constructed by combining Rad-score and independent clinical features and was assessed with a calibration curve. The performance of the radiomics nomogram, Rad-score and TLR was evaluated by receiver operating characteristic (ROC) curves and decision curve analysis (DCA). Results A total of six top weighted radiomics features were selected from PET/CT images by the least absolute shrinkage and selection operator (LASSO) regression algorithm and were used to construct a Rad-score. Multivariate analysis identified Rad-score (OR = 2.183, P = 0.004), age ≤ 50 years (OR = 3.136, P = 0.036), AST > 40U/L (OR = 0.270, P = 0.017) and TLR (OR = 1.641, P = 0.049) as independent predictors of MTM-HCC. The radiomics nomogram had a higher area under the curves (AUCs) than the Rad-score and TLR for predicting MTM-HCC in both training (0.849 [95% CI 0.774–0.924] vs. 0.764 [95% CI 0.669–0.843], 0.763 [95% CI 0.668–0.842]) and validation (0.749 [95% CI 0.584–0.873] vs. 0.690 [95% CI 0.522–0.828], 0.541 [95% CI 0.374–0.701]) cohorts. DCA showed the radiomics nomogram to be more clinically useful than Rad-score and TLR. Conclusions Tumor FDG metabolism is significantly associated with MTM-HCC. A 18F-FDG PET/CT-based radiomics nomogram may be useful for preoperatively predicting the MTM subtype in primary HCC patients, contributing to pretreatment decision-making.
- 23 July 2021
- Published by Wiley in Advanced Healthcare Materials
- Vol. 10 (18) , 2100518
A Honeycomb‐Like Bismuth/Manganese Oxide Nanoparticle with Mutual Reinforcement of Internal and External Response for Triple‐Negative Breast Cancer Targeted Therapy
Triple‐negative breast cancer (TNBC) exhibits aggressive behavior and high levels of metastasis owing to its complex heterogeneous structure and lack of specific receptors. Here, tumor cell membrane (CM)‐coated bismuth/manganese oxide nanoparticles (NPs) with high indocyanine green (ICG) payload up to 50.6 wt% (mBMNI NPs) for targeted TNBC therapy are constructed. The extra‐high drug load Bi@Bi2O3@MnOx NPs (honey‐comb like structure) are formed by Kirkendall effect and electrostatic attraction. After modified with CM, they can home into tumor sites precisely, where they respond to internal overexpressed glutathione (GSH), releasing Mn2+ for chemodynamic therapy (CDT) with GSH depletion, while H2O2 degrades into O2 enabling relief of tumor hypoxia. In response to external near‐infrared irradiation, mBMNI NPs intelligently generate vigorous heat and single oxygen (1O2) for photothermal therapy (PTT) and photodynamic therapy (PDT) owing to high load. Importantly, O2 production and GSH consumption during the internal response reinforce external PDT, while the heat generated through PTT during the external response promotes internal CDT. The honeycomb‐like structure with high ICG load and mutual reinforcement between internal and external response results in excellent therapeutic effects against TNBC.
- 23 July 2021
- Published by Wiley in Advanced Healthcare Materials
- Vol. 10 (18) , 2100518
A Honeycomb‐Like Bismuth/Manganese Oxide Nanoparticle with Mutual Reinforcement of Internal and External Response for Triple‐Negative Breast Cancer Targeted Therapy
Triple‐negative breast cancer (TNBC) exhibits aggressive behavior and high levels of metastasis owing to its complex heterogeneous structure and lack of specific receptors. Here, tumor cell membrane (CM)‐coated bismuth/manganese oxide nanoparticles (NPs) with high indocyanine green (ICG) payload up to 50.6 wt% (mBMNI NPs) for targeted TNBC therapy are constructed. The extra‐high drug load Bi@Bi2O3@MnOx NPs (honey‐comb like structure) are formed by Kirkendall effect and electrostatic attraction. After modified with CM, they can home into tumor sites precisely, where they respond to internal overexpressed glutathione (GSH), releasing Mn2+ for chemodynamic therapy (CDT) with GSH depletion, while H2O2 degrades into O2 enabling relief of tumor hypoxia. In response to external near‐infrared irradiation, mBMNI NPs intelligently generate vigorous heat and single oxygen (1O2) for photothermal therapy (PTT) and photodynamic therapy (PDT) owing to high load. Importantly, O2 production and GSH consumption during the internal response reinforce external PDT, while the heat generated through PTT during the external response promotes internal CDT. The honeycomb‐like structure with high ICG load and mutual reinforcement between internal and external response results in excellent therapeutic effects against TNBC.
- Open Access
- 1 January 2021
- Published by Ivyspring International Publisher in Theranostics
- Vol. 11 (17) , 8448-8463
Biodegradable manganese engineered nanocapsules for tumor-sensitive near-infrared persistent luminescence/magnetic resonance imaging and simultaneous chemotherapy
Rationale: Near-Infrared persistent luminescence (NIR-PL) nanomaterials that can continually emit low-energy photons after ceasing excitation has emerged as a new generation of theranostic nanoparticle drug delivery systems (NDDSs) for imaging-guided cancer therapy, which stems from their special ability to completely avoid tissue autofluorescence interference. However, unresponsive diagnostic capability, inefficient drug delivery, and poor biodegradability limit the efficacy of most reported NIR-PL-based NDDSs.
- 1 January 2021
- Published by Ivyspring International Publisher in Theranostics
- Vol. 11 (17) , 8448-8463
Open AccessBiodegradable manganese engineered nanocapsules for tumor-sensitive near-infrared persistent luminescence/magnetic resonance imaging and simultaneous chemotherapy
Rationale: Near-Infrared persistent luminescence (NIR-PL) nanomaterials that can continually emit low-energy photons after ceasing excitation has emerged as a new generation of theranostic nanoparticle drug delivery systems (NDDSs) for imaging-guided cancer therapy, which stems from their special ability to completely avoid tissue autofluorescence interference. However, unresponsive diagnostic capability, inefficient drug delivery, and poor biodegradability limit the efficacy of most reported NIR-PL-based NDDSs.
- 1 November 2019
- Published by Elsevier in Brain Stimulation
- Vol. 12 (6) , 1610-1611
God locked you in the room, but left a window open: A case report of spinal cord stimulation in locked-in syndrome
- 1 November 2019
- Published by Elsevier in Brain Stimulation
- Vol. 12 (6) , 1610-1611
God locked you in the room, but left a window open: A case report of spinal cord stimulation in locked-in syndrome